fasenra
astrazeneca indonesia - indonesia - benralizumab - larutan injeksi - 30 mg
fasenra pen
astrazeneca indonesia - indonesia - benralizumab - larutan injeksi - 30 mg
keytruda
organon pharma indonesia tbk - indonesia - pembrolizumab - cairan untuk infus - 100 mg
keytruda
merck sharp & dohme pharma - indonesia - pembrolizumab - cairan injeksi - 25 mg/ml
keytruda
organon pharma indonesia tbk - indonesia - pembrolizumab - cairan untuk infus - 100 mg
hemlibra
boehringer ingelheim indonesia - indonesia - emicizumab - cairan injeksi - 30 mg/ml
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 105 mg
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 150 mg
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 30 mg
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 60 mg